References
- DugelPUBandelloFLoewensteinADexamethasone intravitreal implant in the treatment of diabetic macular edemaClin Ophthalmol201591321133526213460
- Electronics Medicine CompendiumSummary of Product Characteristics for ILUVIEN 190 micrograms intravitreal implant in applicator Available from: https://www.medicines.org.uk/emc/medicine/27636Accessed August 4, 2015
- Alimera Sciences Press ReleasesAlpharettaAlimera Sciences, Inc Available from: http://investor.alimerasciences.com/releases.cfmAccessed August 4, 2015
- CampochiaroPANguyenQDHafizGFAMOUS Study GroupAqueous levels of fluocinolone acetonide after administration of fluocinolone acetonide inserts or fluocinolone acetonide implantsOphthalmology2013120358358723218184
- CampochiaroPABrownDMPearsonAFAME Study GroupSustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edemaOphthalmology2012119102125213222727177
References
- DugelPUBandelloFLoewensteinADexamethasone intravitreal implant in the treatment of diabetic macular edemaClin Ophthalmol201591321133526213460
- BoyerDSYoonYHBelfortRJrOzurdex MEAD Study GroupThree-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edemaOphthalmology20141211904191424907062
- CampochiaroPABrownDMPearsonAFAME Study GroupSustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edemaOphthalmology20121192125213222727177